Development and validation of a self-report lower-extremity lymphedema screening questionnaire in women

Physical Therapy

Volumn 93, Issue 5, 2013, Pages 694-703

  Yost, Kathleen J ^a   Cheville, Andrea L ^a   Weaver, Amy L ^a   Hilli, Mariam Al ^a   Dowdy, Sean C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LEG; LYMPH NODE DISSECTION; LYMPHEDEMA; MASS SCREENING; METHODOLOGY; OBESITY; QUESTIONNAIRE; SELF REPORT; VALIDATION STUDY;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOWER EXTREMITY; LYMPH NODE EXCISION; LYMPHEDEMA; MASS SCREENING; OBESITY; QUESTIONNAIRES; SELF REPORT;

MLCS; MLOWN;

EID: 84877090646     PISSN: 00319023     EISSN: 15386724     Source Type: Journal    
DOI: 10.2522/ptj.20120088     Document Type: Article

References (24)

1. Zuther J. Lymphedema Management: The Comprehensive Guide for Practitioners. 2nd ed. Stuttgart, Germany: Thieme; 2009.
2. Cheville AL, McGarvey CL, Petrek JA, et al. Lymphedema management. Semin Radiat Oncol. 2003;13:290-301.
3. Szuba A, Rockson SG. Lymphedema: classification, diagnosis and therapy. Vasc Med. 1998;3:145-156.
4. Beesley V, Janda M, Eakin E, et al. Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer. 2007;109: 2607-2614.
5. Lockwood-Rayermann S. Lymphedema in gynecologic cancer survivors: an area for exploration? Cancer Nurs. 2007;30: E11-E18.
6. Ryan M, Stainton MC, Slaytor EK, et al. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. AustNZJObstet Gynaecol. 2003;43:148-151.
7. Norman SA, Localio AR, Potashnik SL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009; 27:390-397.
8. Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52:370-379.
9. Kosir MA, Rymal C, Koppolu P, et al. Surgical outcomes after breast cancer surgery: measuring acute lymphedema. J Surg Res. 2001;95:147-151.
10. Norman SA, Miller LT, Erikson HB, et al. Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer. Phys Ther. 2001;81:1192-1205.
11. Launois R, Mègnigbêto A, LeLay K, Alliot F. A specific quality of life scale in upper limb lymphedema: the ULL-27 questionnaire. Value Health. 2001;4:407-408.
12. Cella D, ed. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System, Version 4.1. Evanston, IL: Center on Outcomes, Research & Education (CORE); 2004.
13. Crocker L, Algina J. Introduction to Classical and Modern Test Theory. Orlando, FL: Harcourt Brace Jovanovich College Publishers; 1986.
14. Striener D, Norman G: Health Measurement Scales: A Practical Guide to Their Development and Use. 4th ed. New York, NY: Oxford University Press; 2008.
15. Cheville AL, McGarvey CL, Petrek JA, et al. The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol. 2003; 13:214-225.
16. International Society of Lymphology.The diagnosis and treatment of peripheral lymphedema: 2009 Consensus Document of the International Society of Lymphology. Lymphology. 2009;42:51-60.
17. de Vet H, Terwee CB, Mokkink L, Knol D. Measurement in Medicine: A Practical Guide. New York, NY: Cambridge University Press; 2011.
18. Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report, part 2: assessing respondent understanding. Value Health. 2011;14:978-988.
19. Fairclough DL, Cella DF. Functional Assessment of Cancer Therapy (FACT-G): non-response to individual questions. Qual Life Res. 1996;5:321-329.
20. Guyatt G, Rennie D, eds. Users' Guides to the Medical Literature. Chicago, IL: American Medical Association Press; 2002.
21. Hanley J, McNeil B. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-63.
22. Langbecker D, Hayes SC, Newman B, Janda M. Treatment for upper-limb and lower-limb lymphedema by professionals specializing in lymphedema care. Eur J Cancer Care (Engl). 2008;17:557-564.
23. Cheville AL, Almoza M, Courmier JN, Basford JR. A prospective cohort study defining utilities using time trade-offs and the EuroQol-5D to assess the impact of cancerrelated lymphedema. Cancer. 2010;116: 3722-3731.
24. Tsai RJ, Dennis LK, Lynch CF, et al. The risk of developing arm lymphedema among breast cancer survivors: a metaanalysis of treatment factors. Ann Surg Oncol. 2009;16:1959-1972.